[Review of current issues of diagnosis and prevention of blood-borne nosocomial viral infections]

Vopr Virusol. 2019;64(6):262-267. doi: 10.36233/0507-4088-2019-64-6-262-267.
[Article in Russian]

Abstract

Provision of infection security in transplantology and transfusiology is a challenging and significant problem that depends on the quality of medical donor selection and laboratory diagnosis of the blood collected. At present, a large number of blood-borne viruses are known; nevertheless, in Russia, the list of viral agents to be tested during the examination by the blood service boils down to three ones: HIV, hepatitis C and hepatitis B viruses. The review article demonstrates the need for implementation of additional laboratory tests for the agents of the priority healthcare-associated blood-borne infections (HAI) using a risk-based approach, i.e., on specified sites and in high risk groups. It presents a methodology for determination of a quantitative blood-induced infection residual risk (BIRR) index to be used while evaluating the efficiency of viral security provision in the blood service.

Keywords: blood-borne nosocomial viral infections; hemotransfusion; residual risk of a blood-induced infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Blood Transfusion
  • Deltaretrovirus Infections / diagnosis
  • Deltaretrovirus Infections / epidemiology
  • Deltaretrovirus Infections / prevention & control*
  • Deltaretrovirus Infections / virology
  • Disease Transmission, Infectious / prevention & control*
  • Disease Transmission, Infectious / statistics & numerical data
  • HIV Infections / diagnosis
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • HIV Infections / virology
  • HIV-1 / pathogenicity
  • HIV-1 / physiology
  • HIV-2 / pathogenicity
  • HIV-2 / physiology
  • Hepacivirus / pathogenicity
  • Hepacivirus / physiology
  • Hepatitis B virus / pathogenicity
  • Hepatitis B virus / physiology
  • Hepatitis, Viral, Human / diagnosis
  • Hepatitis, Viral, Human / epidemiology
  • Hepatitis, Viral, Human / prevention & control*
  • Hepatitis, Viral, Human / virology
  • Herpes Simplex / diagnosis
  • Herpes Simplex / epidemiology
  • Herpes Simplex / prevention & control*
  • Herpes Simplex / virology
  • Human T-lymphotropic virus 1 / pathogenicity
  • Human T-lymphotropic virus 1 / physiology
  • Human T-lymphotropic virus 2 / pathogenicity
  • Human T-lymphotropic virus 2 / physiology
  • Humans
  • Russia / epidemiology
  • Simplexvirus / pathogenicity
  • Simplexvirus / physiology
  • Tissue Transplantation